Sector ratings Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. Other stock markets 08/06/2026			5-day change	1st Jan Change
148.34 ^CHF	0.00%		0.00%	-

06-05	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT
06-03	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LONZA GROUP AG	43.03B		AAA
REVOLUTION MEDICINES, INC.	32.71B	-	B	-		-
IQVIA HOLDINGS INC.	30.29B		AAA
BEONE MEDICINES AG	29.4B		-
CELLTRION, INC.	25.08B		A
ASCENDIS PHARMA A/S	13.54B	-	-	-		-		-
MEDPACE HOLDINGS, INC.	13.35B		BBB
EUROFINS SCIENTIFIC SE	12.97B		AA
IONIS PHARMACEUTICALS, INC.	12.11B	-	A	-		-
ICON PUBLIC LIMITED COMPANY	11.19B		AAA
REGENCELL BIOSCIENCE HOLDINGS LIMITED	9.33B	-	-	-	-	-	-	-
TEMPUS AI, INC.	8.59B		A			-
BIO-TECHNE CORPORATION	8.45B		AA
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
ABIVAX	7.85B	-	BBB	-		-
QIAGEN N.V.	7.66B		AAA
PRAXIS PRECISION MEDICINES, INC.	7.43B	-	B	-		-
ALKERMES PLC	7.38B		A
KYMERA THERAPEUTICS, INC.	7.09B	-	BBB	-		-
Average	15.57B		A
Weighted average by Cap.			A